Cream tested to soothe painful side effect of cancer treatment
NCT ID NCT03471364
Summary
This early study tested whether a cream containing ketoconazole could reduce the severity of a skin rash caused by a common class of cancer drugs (EGFR inhibitors). 58 patients with cancer who developed this rash were randomly assigned to use either the ketoconazole cream or a placebo cream for 28 days. The main goal was to see if the ketoconazole cream improved patients' rash symptoms and quality of life compared to the placebo.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT NEOPLASM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Carle Cancer Center
Urbana, Illinois, 61801, United States
-
Carle on Vermilion
Danville, Illinois, 61832, United States
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
-
Park Nicollet Frauenshuh Cancer Center
Saint Louis Park, Minnesota, 55426, United States
-
Regions Hospital
Saint Paul, Minnesota, 55101, United States
-
University of Rochester
Rochester, New York, 14642, United States
Conditions
Explore the condition pages connected to this study.